Previous 10 | Next 10 |
BOSTON, Jan. 19, 2024 (GLOBE NEWSWIRE) -- Block & Leviton LLP ( www.blockleviton.com ), a national securities litigation firm, announces that it has filed a class action lawsuit on behalf of shareholders against BioVie, Inc. (NASDAQ: BIVI) and certain of its executives, for securities fra...
SAN FRANCISCO, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges BioVie Inc. (NASDAQ: BIVI) investors who suffered substantial losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/BIVI Contact An Attorney Now: BIVI@hbsslaw.com 844-916-08...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In BioVie To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in BioVie and would like to discuss your legal rights, call Faruqi & Faruqi partner Jos...
ORLANDO, FL / ACCESSWIRE / January 5, 2024 / RedChip Companies will air interviews with bioAffinity Technologies, Inc. (NASDAQ:BIAF) and BioVie, Inc. (NASDAQ:BIVI) on The RedChip Small Stocks Big Money® Show, a sponsored program on Bloomberg TV, this Saturday, January 5, at 7 p.m. Eastern T...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In BioVie To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in BioVie and would like to discuss your legal rights, call Faruqi & Faruqi partner Jos...
ORLANDO, FL / ACCESSWIRE / December 29, 2023 / RedChip Companies will air interviews with Genetic Technologies Limited (NASDAQ:GENE) and BioVie, Inc. (NASDAQ:BIVI) on The RedChip Small Stocks Big Money® Show, a sponsored program on Bloomberg TV, this Saturday, December 30, at 7 p.m. Eastern...
ORLANDO, FL / ACCESSWIRE / December 22, 2023 / RedChip Companies will air interviews with Rail Vision (NASDAQ:RVSN) and BioVie, Inc. (NASDAQ:BIVI) on The RedChip Small Stocks Big Money® Show, a sponsored program on Bloomberg TV, this Saturday, December 23, at 7 p.m. Eastern Time (ET). Bloom...
2023-12-04 10:48:50 ET More on BioVie Inc. BioVie: Update Following Topline Results (Rating Downgrade) BioVie plunges after Alzheimer’s study missed statistical significance Prothena, BioVie among decliners after Biogen data for new Alzheimer’s therapy ...
2023-12-02 00:44:02 ET Summary Misconduct issues were identified in several trial sites, leading to exclusion of majority of enrolled patients and a severely underpowered study. BIVI presented promising signals of efficacy but with many limitations. BIVI plans to resume enrolling ...
ATLANTA, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether BioVie Inc. (“BioVie” or the “Company”) (NASDAQ: BIVI) complied with federal securities laws. On November 29, 2023, BioVie Inc. announced topline efficacy data from its P...
News, Short Squeeze, Breakout and More Instantly...
BioVie Inc. Company Name:
BIVI Stock Symbol:
OTCMKTS Market:
Full Dataset from Phase 2a trial in Parkinson’s Disease suggest patients treated with bezisterim experienced significant improvements in both non-motor symptoms and motor control while placebo-treated patients worsened Improvements in non-motor symptoms correlated with improv...
Jet.AI Inc. (JTAI) is expected to report for Q1 2024 Forian Inc. (FORA) is expected to report $-0.02 for Q1 2024 Square Enix Holdings Co. Ltd (SQNXF) is expected to report for Q4 2024 Qutoutiao Inc. (QTT) is expected to report for Q4 2023 Molecular Partners AG (MOLN) is expected t...